Prefrontal Oscillations in Social Anxiety Disorder (POSAD)
A legfontosabb adatok
- Ki végzi
- Institut National de la Santé Et de la Recherche Médicale, France
- Hol
- Franciaország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 20 fő vett részt
- Kezdés
- 2019. nov. 12.
- Befejezés
- 2026. máj. 9.
- A vizsgálat típusa
- Beavatkozással járó, 3 csoport
- A vizsgált kezelések
- In vivo social exposure
- Social exposure in a virtual reality setting
- EEG recording
- Psychometric evaluation
- Visual Analogue Scale of anxiety
- A regiszteradat frissítve
- 2026. július 7.
Ki vehet részt
- Életkor
- 20 év – 50 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 14 feltétel megnézéseKevesebb
Ki vehet részt
- Social anxiety disorder as defined in DSM-5
- Full understanding of the protocol
- Obtaining informed consent from study subjects before or at inclusion at the latest
- Being registered in the french national health insurance service (Sécurité Sociale) (or equivalent)
Ki nem vehet részt
- initiation of a psychotropic treatment or change in the dose of ongoing psychotropic treatment within 3 days prior to each visit and including:; antidepressant treatments with selective serotonin recapture inhibitors, serotonin and norepinephrine inhibitors, alpha2-presynaptic adrenoreceptors (mirtazapine, mianserin), tricyclic; anxiolytic drugs including benzodiazepines and anti-histamine; antipsychotic drugs
- Acute alcohol intake 2 days prior to each visit (inclusion, experimental sessions)
- Active medical co-morbidity including severe hypertension, cardiac insufficiency, Raynaud syndrome, diabetes mellitus, renal insufficiency, adrenal insufficiency, Cushing syndrome and epilepsy
- Severe neurological co-morbidity, including but not limited to Parkinson's disease and multiple sclerosis
- History of significant head injury, defined by loss of consciousness
- Being diagnosed with another major psychiatric condition (DSM5) including bipolar disorder and schizophrenia or substance/alcohol use disorder; with the exception of major depressive disorder and nicotine use disorder
- Long-term corticotherapy
- Suicidal risk evaluated as moderate to high in the MINI questionnaire
- Pregnancy or breastfeeding
- Ongoing hospitalization without consent (decision of a third-party: medical, justice)
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Experimental fear in rodents is correlated with slow oscillations in electrical recordings of prefrontal cortex activities. The present study aims to test whether slow prefrontal oscillations is a biomarker of pathological anxiety in human subjects.
A vizsgálat 3 csoportja
- Group 1: Go-no-go phaseA vizsgált kezelés
The presence of significant prefrontal oscillations in the EEG recording 2-6Hz band during in vivo social exposure (oral presentation to examiners) will be assessed in 10 subjects with social anxiety disorder. EEG will be recorded immediately before, during and after oral presentations to examiners. Psychometric evaluation will be performed prior to experimental sessions. Rating of anxiety levels will be performed by subjects using a Visual Analogue Scale of anxiety during each of the 3 experimental periods (wainting, presentation, recovery). Results of EEG recordings in the first 10 subjects will lead to continuation (presence of significant slow prefrontal oscillations during anxiety) or interruption (absence of signification oscillation) of the study.
Kezelés: In vivo social exposure, EEG recording, Psychometric evaluation és Visual Analogue Scale of anxiety
- Group 2.1A vizsgált kezelés
In group 2.1, 10 subjects will undergo 2 sessions in a cross-over design with EEG recording immediately before, during and after: 1. "real exposure": oral presentation to a panel of examiners 2. "virtual reality" : oral presentation to virtual examiners Rating of anxiety levels will be performed by subjects using a Visual Analogue Scale of anxiety during each of the 3 experimental periods for each session. Psychometric evaluation will be performed prior to experimental sessions.
Kezelés: In vivo social exposure, Social exposure in a virtual reality setting, EEG recording, Psychometric evaluation és Visual Analogue Scale of anxiety
- Group 2.2A vizsgált kezelés
In group 2.2, 10 subjects will undergo 2 sessions in a cross-over design with EEG recording immediately before, during and after: 1. "virtual reality" : oral presentation to virtual examiners 2. "real exposure": oral presentation to a panel of examiners Rating of anxiety levels will be performed by subjects using a Visual Analogue Scale of anxiety during each of the 3 experimental periods for each session. Psychometric evaluation will be performed prior to experimental sessions.
Kezelés: In vivo social exposure, Social exposure in a virtual reality setting, EEG recording, Psychometric evaluation és Visual Analogue Scale of anxiety
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Study of Slow Prefrontal Cortex Oscillations During Social Exposure in Social Anxiety Disorder
- A regiszteradat frissítve
- 2026. július 7.